| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271191 Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer's disease |
| 09/18/2007 | US7271190 Indazole compounds as β3 adrenoceptor agonist |
| 09/18/2007 | US7271189 1H-imidazole derivatives as cannabinoid receptor modulators |
| 09/18/2007 | US7271188 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 09/18/2007 | US7271187 Compositions and methods for promoting tissue regeneration |
| 09/18/2007 | US7271186 glycylboronic acid transition state analogs; effective against class C beta -lactamase AmpC |
| 09/18/2007 | US7271185 Optically active azole derivative and process for producing the same |
| 09/18/2007 | US7271184 For controlling parasites on warm-blooded animals; veterinary medicine |
| 09/18/2007 | US7271183 Bone disorders; osteoporosis; antihistamines; sexual disorders; antiinflammatory agents; antiarthritic agents; vision defects; antiulcer agents |
| 09/18/2007 | US7271182 Salts of benzimidazole compound and use thereof |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271180 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/18/2007 | US7271179 Inhibitors of JAK protein kinase |
| 09/18/2007 | US7271178 Heterocyclic inhibitors of MEK and methods of use thereof |
| 09/18/2007 | US7271177 Solubility, dissolution rate and bioavailability; X-ray diffraction peak pattern comprising broad halo at 2 theta of about 17 degrees |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271175 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 09/18/2007 | US7271174 Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 09/18/2007 | US7271173 Mixed kappa/mu opioids and uses thereof |
| 09/18/2007 | US7271172 Pyrrolidine and azetidine compounds as CCR5 antagonists |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271170 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 09/18/2007 | US7271169 1,4-disubstituted piperazine compounds; for example 2-{4-[2-(acetylamino)-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-(3-phenylphenyl)acetamide; cardiovascular diseases such as arrhythmias, intermittent claudication, angina, congestive heart disease, diabetes, and myocardial infarction |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/18/2007 | US7271167 Compounds, compositions, and methods |
| 09/18/2007 | US7271165 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-5'-[4-isobutyl-1-piperazinyl]benzoxazinorifamycin |
| 09/18/2007 | US7271164 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders |
| 09/18/2007 | US7271163 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 09/18/2007 | US7271162 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 09/18/2007 | US7271161 Platinum complexes as antitumor agents in combination with biochemical modulation |
| 09/18/2007 | US7271160 Firt and second hsp(heat shock protein)-binding moieties joined by a linker, which bind to the pocket of hsp90 with which ansamycin antibiotics bind; linked geldanamycin, for example; treating cancer |
| 09/18/2007 | US7271159 Camptothecin analogs and methods of preparation thereof |
| 09/18/2007 | US7271158 Veterinary medicine |
| 09/18/2007 | US7271157 Contacting (4S,2R,3R,5R)-2-(6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol with a protected (2-hydroxy) cyclopentylamine compound having a protecting group on the 2-hydroxy moiety;contacting=with thionyl chloride in the presence of a second base;contacting with base, removing protecting group |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271155 9A, 11-2C-bicyclic 9a-azalide derivatives |
| 09/18/2007 | US7271154 Such as penicillin G coupled to 2'deoxyazithromycin; drug delivery |
| 09/18/2007 | US7271153 Treating diseases associated with hyperglycemia such as diabetes; SGLT2 (sodium/glucose cotransporter 2) inhibitor; 3-(4-Ethylbenzyl)-2-(beta-D-glucopyranosyloxy)-4,6-dimethyl-pyridine for example |
| 09/18/2007 | US7271152 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271146 Methods for treatment of Helicobacter pylori-associated disorders |
| 09/18/2007 | US7271137 Neutralize biological pathogens; sterilization of medical equipment; food processing equipment; mixture of bleaching activator, base and water |
| 09/18/2007 | US7270966 for drug screening agents for treatment and/or prevention of cystic fibrosis by receptor binding ligand; genetic engineering |
| 09/18/2007 | US7270840 Mixture of quercetin, vitamins, catechin and caffeine; sexual disorders; inflammatory bowel disorders |
| 09/18/2007 | US7270838 Composition for treating chronic venous insufficiencies using an extract of red vine leaves |
| 09/18/2007 | US7270836 Cyclooxygenase-2 inhibitory withanolide compositions and method |
| 09/18/2007 | US7270835 COX-2 inhibitors; compounds which inhibit synthesis of prostaglandins |
| 09/18/2007 | US7270834 For use in the treatment of several diseases such as diseases of the feet in animals, such as the hooves in horses, arthritis, muscular affections, etc. in human beings |
| 09/18/2007 | US7270833 Use of potassium for production of cardioplegic solution for prevention of stone heart development during acute cardiac ventricular fibrillation in connection with cardiopulmonary resuscitation |
| 09/18/2007 | US7270831 Orally administrable opioid formulations having extended duration of effect |
| 09/18/2007 | US7270830 Transdermal buprenorphine dosage regimen for analgesia |
| 09/18/2007 | US7270818 Treating brain disorder by administering a therapeutically effective amount of antisense oligonucleotide; preventing the formation of Alzheimer senile plaques |
| 09/18/2007 | US7270808 Having covalently coupled bioactive agent and targeting ligand; controlled release; stability, solubility; reduced toxicity |
| 09/18/2007 | US7270805 N-acylbenzothiazolone derivatives in a cosmetically acceptable carrier; for reducing the irritation associated with irritating skin benefit agents, such as retinol |
| 09/18/2007 | US7270800 Imaging amyloid deposits in living patients, with an amyloid binding agents having radiolabeled iodine; radiotherapy |
| 09/18/2007 | US7270799 compounds such as 2-methyl-2(3-fluoropropyl)-malonic Acid that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, i.e., cells undergoing cell death, apoptotic cells or activated platelets |
| 09/18/2007 | CA2417106C Piperazine derivatives |
| 09/18/2007 | CA2416229C Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 09/18/2007 | CA2414680C Methods for treating inflammation-mediated conditions of the eye |
| 09/18/2007 | CA2413624C Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode |
| 09/18/2007 | CA2411957C Novel process for the preparation of pyrazolopyrimidinones |
| 09/18/2007 | CA2392473C Bioadhesive drug delivery system |
| 09/18/2007 | CA2388325C Ciclesonide-containing aqueous pharmaceutical composition |
| 09/18/2007 | CA2388322C Ciclesonide contained pharmaceutical composition for application to mucosa |
| 09/18/2007 | CA2365359C Medicaments containing a sulfopyranosylglycerol derivative |
| 09/18/2007 | CA2348948C .beta.-l-2'-deoxy-nucleosides for the treatment of hiv infection |
| 09/18/2007 | CA2344481C Compositions containing biologically-active phenolic compounds |
| 09/18/2007 | CA2338859C Estradiol-containing patch for transdermal administration of hormones |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2323809C A method for chemoprevention of prostate cancer |
| 09/18/2007 | CA2319609C Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
| 09/18/2007 | CA2315228C Layered rate controlling membranes for use in an electrotransport device |
| 09/18/2007 | CA2308677C 4'-c-ethynyl purine nucleoside compounds |
| 09/18/2007 | CA2308192C 4'-c-ethynyl pyrimidine nucleoside compounds |
| 09/18/2007 | CA2307888C Spine distraction implant |
| 09/18/2007 | CA2307298C Skin care composition comprising dipotassium glycyrrhizinate, tretinoin and hydroquinone |
| 09/18/2007 | CA2297832C Pellet-type formulation intended for treating the intestinal tract |
| 09/18/2007 | CA2287991C New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments |
| 09/18/2007 | CA2282513C Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 09/18/2007 | CA2279200C Anaesthetic bone cement |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2271162C Stearidonic acid compositions and uses thereof |
| 09/18/2007 | CA2270952C New use for 1,3-propanediol derivatives |
| 09/18/2007 | CA2269698C Agent for treating neurodegenerative disorders |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2259621C Isocoumarin derivatives and their use in medicines |
| 09/18/2007 | CA2259420C Erythromycins and process for their preparation |
| 09/18/2007 | CA2248179C .beta.-lactam antibiotic-containing tablet and production thereof |
| 09/18/2007 | CA2243234C 5h-thiazolo[3,2-a]pyrimidine derivatives |
| 09/18/2007 | CA2236648C Sulfatation of estrogen mixtures |
| 09/18/2007 | CA2221991C Di- and trivalent small molecule selectin inhibitors |
| 09/18/2007 | CA2221771C Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase |
| 09/18/2007 | CA2220533C 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them |
| 09/18/2007 | CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them |
| 09/18/2007 | CA2201812C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 09/18/2007 | CA2176719C Fatty acid delivery system |
| 09/18/2007 | CA2174133C Use of alpha receptor antagonists for the treatment of chronic muscle pain |
| 09/18/2007 | CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 09/18/2007 | CA2124605C Prevention and improvement of medical symptoms caused by leucotriene b4 |